+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts by Product, Disease Indication, Technology, End User, and Geography- Product Image
Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts by Product, Disease Indication, Technology, End User, and Geography- Product Image
Sale

Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts by Product, Disease Indication, Technology, End User, and Geography

  • PDF Icon

    Report

  • 165 Pages
  • August 2019
  • Region: Global
  • The Insight Partners
  • ID: 4841389
UP TO OFF until Jun 30th 2024
Description Jump to:
The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027.

The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, the availability of alternative approaches may limit the growth of the market to a certain extent.

Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.

In spite of stringent quality control measures and advanced tools, a limited number of antiviral drugs are getting approved for human use. The mechanism of action of the antiviral drugs can differ, strengthening the immune response to the viral infection and ranging from targeting viral proteins to cellular proteins. Apart from antiviral drugs, some alternative approaches are used for the treatment of viral diseases. These approaches include antisense oligonucleotides, aptamers, immunomodulators, vaccines, and ribozymes. The antisense nucleotide method comprises targeting specific nucleotides rather than proteins. Besides, oligonucleic acid or peptide molecules that bind to a particular target molecule is known as Aptamer. The peptide aptamers are used to treat viral infections. The peptide aptamers are designed to restrict other protein interactions inside the cells.

Global antiviral drug resistance were segmented by product, disease indication, technology, and end user. The product segment was categorized as kits & reagents and instruments. On the basis of the disease indication, the market is segmented as Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV]. Similarly, based on technology, the market is fragmented as, immunodiagnostics, polymerase chain reaction [PCR], next generation sequencing [NGS], and other technologies. Based on end user, the antiviral drug resistance market is categorized as, hospitals & clinics, pathology or diagnostic laboratories and research institutes.

Some of the major primary and secondary sources included in the report include, National Cancer Institute, National AIDS Research Institute, International Diabetes Federation, Centers for Disease Control and Prevention, and Food and Drug Administration, among others.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Antiviral Drug Resistance Market - By Product
1.3.2 Global Antiviral Drug Resistance Market - By Disease Indication
1.3.3 Global Antiviral Drug Resistance Market - By Technology
1.3.4 Global Antiviral Drug Resistance Market - By End User
1.3.5 Global Antiviral Drug Resistance Market - By Geography
2. Global Antiviral Drug Resistance Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antiviral Drug Resistance Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinion
4.4 Cost of Test, By Test Type
4.5 Test Volume, By Region
5. Global Antiviral Drug Resistance Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in the Incidences of Hepatitis Diseases
5.1.2 Increasing Prevalence of HIV/AIDS
5.2 Key Market Restraints
5.2.1 Alternative Approaches
5.3 Key Market Opportunities
5.3.1 Increasing Healthcare Expenditures in Emerging Markets
5.4 Future Trends
5.4.1 Demand For Higher Quality Products
5.5 Impact Analysis
6. Antiviral Drug Resistance Market - Global Analysis
6.1 Global Antiviral Drug Resistance Market Revenue Forecasts And Analysis
6.2 Global Antiviral Drug Resistance Market, By Geography - Forecasts And Analysis
6.3 Positioning of Key Players
7. Global Antiviral Drug Resistance Market Analysis- by Product
7.1 Overview
7.2 Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Antiviral Drug Resistance Market Analysis- by Disease Indication
8.1 Overview
8.2 Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
8.3 HIV
8.3.1 Overview
8.3.2 HIV Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Cytomegalovirus (CMV)
8.5.1 Overview
8.5.2 Cytomegalovirus (CMV) Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Antiviral Drug Resistance Market Analysis- by Technology
9.1 Overview
9.2 Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
9.3 Immunodiagnostics
9.3.1 Overview
9.3.2 Immunodiagnostics Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Polymerase Chain Reaction (PCR)
9.4.1 Overview
9.4.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Next Generation Sequencing (NGS)
9.5.1 Overview
9.5.2 Next Generation Sequencing (NGS) Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 Other Technologies Market Revenue and Forecast to 2027 (US$ Mn)
10. Global Antiviral Drug Resistance Market Analysis- by End User
10.1 Overview
10.2 Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals And Clinics Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Pathology and Diagnostic Laboratories
10.4.1 Overview
10.4.2 Pathology and Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10.4.3 List of Laboratories, By Region
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes Market Revenue and Forecast to 2027 (US$ Mn)
11. Antiviral Drug Resistance Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 North America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.1.1 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.4 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.5 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.6 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.7.3 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.7.4 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.7.5 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.8.3 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.8.4 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.8.5 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.9 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.9.3 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.9.4 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.9.5 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.2.1 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.3 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.4 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.5 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.3 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.7.4 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.7.5 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.3 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.8.4 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.8.5 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.3 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.9.4 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.9.5 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.10.3 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.10.4 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.10.5 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.11.3 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.11.4 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.11.5 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027
11.3.1 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.2 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.3 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.4 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.5 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.6 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.3.7 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.1 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.2 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.7.3 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.7.4 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.7.5 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.8 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.8.3 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.8.4 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.8.5 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.9 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.1 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.9.3 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.9.4 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.9.5 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.10 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.10.3 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.10.4 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.10.5 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.11 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.1 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.11.3 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.11.4 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.11.5 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.4.1 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.3 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.5 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.6 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.4.7 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.7.3 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.7.4 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.7.5 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.8 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.8.3 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.8.4 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.8.5 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.9 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.9.3 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.9.4 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.9.5 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5 South And Central America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.5.1 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.3 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.4 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.5 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.6 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.2 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.7.3 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.7.4 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.7.5 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.8 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.8.3 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.8.4 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.8.5 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Antiviral Drug Resistance Market- Industry Landscape
12.1 Overview
13. Antiviral Drug Resistance Market-Key Company Profiles
13.1 AccuBioTech Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ACON Laboratories, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 bioMérieux SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Information
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Information
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Abbott
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BD
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Trinity Biotech
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publishers
14.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Danaher
  • Abbott
  • BD
  • F. Hoffmann-La Roche Ltd
  • Trinity Biotech
  • Seimens AG
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.

Related Topics

Related Reports

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Antiviral Combination Therapy Global Market Report 2024 - Product Image

Antiviral Combination Therapy Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 189 Pages
  • Global
From
Global Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029 - Product Image

Global Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

  • Report
  • 215 Pages
  • Global
From
Global Direct-acting Antiviral Drug Market by Type (NS3/4A Protease, NS5A Protein, NS5B RNA-Dependent RNA polymerase), Indication (Hepatitis C Virus, HIV Infection/ AIDS, Influenza), Route, Distribution Channel - Forecast 2024-2030 - Product Image

Global Direct-acting Antiviral Drug Market by Type (NS3/4A Protease, NS5A Protein, NS5B RNA-Dependent RNA polymerase), Indication (Hepatitis C Virus, HIV Infection/ AIDS, Influenza), Route, Distribution Channel - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.